300 related articles for article (PubMed ID: 18448355)
1. Hyalurondiase: both a tumor promoter and suppressor.
Lokeshwar VB; Selzer MG
Semin Cancer Biol; 2008 Aug; 18(4):281-7. PubMed ID: 18448355
[TBL] [Abstract][Full Text] [Related]
2. Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases.
Isoyama T; Thwaites D; Selzer MG; Carey RI; Barbucci R; Lokeshwar VB
Glycobiology; 2006 Jan; 16(1):11-21. PubMed ID: 16166602
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronidase inhibitors: a biological and therapeutic perspective.
Girish KS; Kemparaju K; Nagaraju S; Vishwanath BS
Curr Med Chem; 2009; 16(18):2261-88. PubMed ID: 19519390
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressor genes in pancreatic cancer.
Hruban RH; Offerhaus GJ; Kern SE; Goggins M; Wilentz RE; Yeo CJ
J Hepatobiliary Pancreat Surg; 1998; 5(4):383-91. PubMed ID: 9931387
[No Abstract] [Full Text] [Related]
5. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview.
Girish KS; Kemparaju K
Life Sci; 2007 May; 80(21):1921-43. PubMed ID: 17408700
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by tumor suppressor genes and oncogenes.
Canman CE; Kastan MB
Semin Cancer Biol; 1995 Feb; 6(1):17-25. PubMed ID: 7548837
[TBL] [Abstract][Full Text] [Related]
7. Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis.
Kopnin BP
Biochemistry (Mosc); 2000 Jan; 65(1):2-27. PubMed ID: 10702637
[TBL] [Abstract][Full Text] [Related]
8. Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
Ho A; Dowdy SF
Curr Opin Genet Dev; 2002 Feb; 12(1):47-52. PubMed ID: 11790554
[TBL] [Abstract][Full Text] [Related]
9. Biological actions of oncogenes.
Smith MR; Matthews NT; Jones KA; Kung HF
Pharmacol Ther; 1993; 58(2):211-36. PubMed ID: 8415879
[TBL] [Abstract][Full Text] [Related]
10. The proliferation of Drosophila in cancer research: a system for the functional characterization of tumor suppressors and oncogenes.
Rabinow L
Cancer Invest; 2002; 20(4):531-56. PubMed ID: 12094549
[No Abstract] [Full Text] [Related]
11. Molecular pathology of pancreatic cancer.
Hruban RH; Iacobuzio-Donahue C; Wilentz RE; Goggins M; Kern SE
Cancer J; 2001; 7(4):251-8. PubMed ID: 11561601
[TBL] [Abstract][Full Text] [Related]
12. Malignancy: an evolving definition of a cancer cell.
Williams JL
Clin Lab Sci; 2002; 15(1):37-43. PubMed ID: 12778955
[No Abstract] [Full Text] [Related]
13. Oncogenes, cancer and imaging.
Urbain JL
J Nucl Med; 1999 Mar; 40(3):498-504. PubMed ID: 10086717
[TBL] [Abstract][Full Text] [Related]
14. In this issue--oncogenes, tumor suppressor genes and melanocytic lesions.
Udey MC; Hornyak TJ
J Invest Dermatol; 2004 May; 122(5):VII-VIII. PubMed ID: 15140248
[No Abstract] [Full Text] [Related]
15. A fluorimetric Morgan-Elson assay method for hyaluronidase activity.
Takahashi T; Ikegami-Kawai M; Okuda R; Suzuki K
Anal Biochem; 2003 Nov; 322(2):257-63. PubMed ID: 14596836
[TBL] [Abstract][Full Text] [Related]
16. [Oncogenes and anti-oncogenes: the genetics of cancer].
Schorderet DF; Munier FL
Praxis (Bern 1994); 1996 Aug; 85(35):1019-22. PubMed ID: 8848670
[TBL] [Abstract][Full Text] [Related]
17. [Oncogenes and tumor-suppressor genes].
Izumiya M; Nakagama H
Nihon Rinsho; 2011 Apr; 69 Suppl 3():72-6. PubMed ID: 22213934
[No Abstract] [Full Text] [Related]
18. Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis.
de Sá VK; Canavez FC; Silva IA; Srougi M; Leite KR
Urol Oncol; 2009; 27(4):377-81. PubMed ID: 18639473
[TBL] [Abstract][Full Text] [Related]
19. Disruption of oncogene/tumor suppressor networks during human carcinogenesis.
Münger K
Cancer Invest; 2002; 20(1):71-81. PubMed ID: 11853005
[TBL] [Abstract][Full Text] [Related]
20. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
Lokeshwar VB; Cerwinka WH; Isoyama T; Lokeshwar BL
Cancer Res; 2005 Sep; 65(17):7782-9. PubMed ID: 16140946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
